By Will Feuer


The Food and Drug Administration authorized Altria Group Inc.-owned U.S. Smokeless Tobacco Co.'s Copenhagen Classic Snuff product to be marketed as a modified-risk tobacco product, or MRTP.

The authorization means that the product, which is a smokeless tobacco product, can be marketed with the language: "IF YOU SMOKE, CONSIDER THIS: Switching completely to this product from cigarettes reduces risk of lung cancer."

The FDA said its staff reviewed available evidence, public comments and recommendations from expert committees and concluded that the claim in the language is accurate.

The company is still required to conduct postmarket surveillance. The modified-risk granted order will expire in five years and the company will need to receive authorization then to continue to market the product as a MRTP, the FDA said.


Write to Will Feuer at


(END) Dow Jones Newswires

March 16, 2023 12:02 ET (16:02 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.
Altria (NYSE:MO)
Historical Stock Chart
From May 2023 to Jun 2023 Click Here for more Altria Charts.
Altria (NYSE:MO)
Historical Stock Chart
From Jun 2022 to Jun 2023 Click Here for more Altria Charts.